The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 335:275-277 July 25, 1996 Number 4
NextNext

Myocardial Revascularization — Bypass Surgery or Angioplasty?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
In this issue of the Journal, the results of the Bypass Angioplasty Revascularization Investigation (BARI), a large clinical trial comparing coronary-artery bypass grafting (CABG) with percutaneous transluminal coronary angioplasty (PTCA), are presented.1 BARI enrolled 1829 patients who were followed for an average of 5.4 years. The authors concluded that for patients with multivessel coronary artery disease and suitable anatomy who prefer to avoid major surgery, "angioplasty offers a reasonable alternative with an expectation of similar overall survival rates and survival rates free of Q-wave myocardial infarction."

This carefully worded conclusion is similar to that derived from a recent meta-analysis of . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.